Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE), improved following surgical resection of prostatic carcinoma: A case report

Shugo Yajima; Tooru Ooeda; Masaharu Inoue; Hiroaki Suzuki; Shunya Matsumoto; Hitoshi Masuda

doi:10.1016/j.eucr.2020.101232

Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE), improved following surgical resection of prostatic carcinoma: A case report

Urol Case Rep. 2020 May 3:32:101232. doi: 10.1016/j.eucr.2020.101232. eCollection 2020 Sep.

Authors

Shugo Yajima¹, Tooru Ooeda², Masaharu Inoue³, Hiroaki Suzuki⁴, Shunya Matsumoto¹, Hitoshi Masuda¹

Affiliations

¹ National Cancer Center Hospital East, Chiba, Japan.
² Nadogaya Abiko Hospital, Chiba, Japan.
³ Saitama Cancer Center, Saitama, Japan.
⁴ Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

Abstract

RS3PE syndrome is a rare condition that occurs in elderly individuals which can present alone or in association with various rheumatic or malignant diseases. We present a case of a 77-year-old man who was diagnosed with adenocarcinoma of the prostate and initially under active surveillance. 2 months after the diagnosis, he presented with arthralgia in both shoulders and knees, pitting edema of the both hands and feet. The patient underwent radical prostatectomy since the link between prostatic carcinoma and RS3PE was suspected. After 7 months from operation, the patient has no symptoms or signs of RS3PE.

Keywords: ANA, (antinuclear antibody); Anti-CCP, (Anti-cyclic citrullinated peptide); CRP, (C reactive protein); Corticosteroids; Interleukin 6, (IL-6); MMP-3, Matrix metalloproteinase-3); PSA, (Prostate-specific antigen); Paraneoplastic syndrome; Prostate cancer; RS3PE; Remitting seronegative symmetrical synovitis with pitting edema, (RS3PE); Rheumatoid factor, (RF); Tumor necrosis factor a, (TNF-a).

Publication types

Case Reports